Non-cardiac surgeries in adults with congenital heart disease -influence of complexity of disease and estimated risk of surgery on adverse events.

IF 6.1 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Alicia Jeanette Friedrich, Robert Radke, Stefan Orwat, Gerrit Kaleschke, Philipp Darius Garthe, Fernando de Torres-Alba, Kevin Willy, Joachim Gerß, Helmut Baumgartner, Gerhard-Paul Diller, Jeanette Köppe
{"title":"Non-cardiac surgeries in adults with congenital heart disease -influence of complexity of disease and estimated risk of surgery on adverse events.","authors":"Alicia Jeanette Friedrich, Robert Radke, Stefan Orwat, Gerrit Kaleschke, Philipp Darius Garthe, Fernando de Torres-Alba, Kevin Willy, Joachim Gerß, Helmut Baumgartner, Gerhard-Paul Diller, Jeanette Köppe","doi":"10.1016/j.ejim.2025.106514","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To provide information on adults with congenital heart disease (ACHD) undergoing non-cardiac surgeries (NCS), specific risk compared non-ACHD, independent risk factors for adverse outcome and mortality.</p><p><strong>Methods: </strong>Based on non-selective data including all in-hospital admissions in Germany from 2009 to 2021, all ACHD cases that underwent NCS were selected. NCS was categorized in low, medium and high-risk procedures. As primary endpoints, major adverse cardiovascular events (MACE), major infection (MIE), major bleeding (MBE), major thromboembolism (MTE), and in-hospital death were defined. Outcomes of ACHD were compared to a propensity score matched cohort of non-ACHD.</p><p><strong>Results: </strong>Overall, 15,349 inpatient ACHD cases were selected for analysis. Of those 72.3 % (n=11,094) were simple, 20.1 % (n=3,086) were moderate and 7.6 % (n=1,169) were complex ACHD. Patients with more than moderate ACHD faced a substantially higher risk for adverse outcome regarding all predefined endpoints compared to non-ACHD. Specifically, risk for MACE was increased with an Odds ratio (OR) of 1.29 (95 % CI 1.11-1.51) for moderate ACHD and OR 1.58 (95 % CI 1.23-2.02) for complex ACHD. In-hospital mortality was OR 1.39 (95 % CI 1.13-1.71) for moderate and OR 2.22 (95 % CI 1.62-3.03) for complex ACHD compared to non-ACHD.</p><p><strong>Conclusions: </strong>Patients with more than moderate complexity ACHD are at specific risk for adverse outcomes when undergoing non-cardiac surgery. Further analyses are needed to give precise recommendations on the choice of appropriate surgical site as well as how to improve care and outcome of ACHD undergoing NCS.</p>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":"106514"},"PeriodicalIF":6.1000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejim.2025.106514","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To provide information on adults with congenital heart disease (ACHD) undergoing non-cardiac surgeries (NCS), specific risk compared non-ACHD, independent risk factors for adverse outcome and mortality.

Methods: Based on non-selective data including all in-hospital admissions in Germany from 2009 to 2021, all ACHD cases that underwent NCS were selected. NCS was categorized in low, medium and high-risk procedures. As primary endpoints, major adverse cardiovascular events (MACE), major infection (MIE), major bleeding (MBE), major thromboembolism (MTE), and in-hospital death were defined. Outcomes of ACHD were compared to a propensity score matched cohort of non-ACHD.

Results: Overall, 15,349 inpatient ACHD cases were selected for analysis. Of those 72.3 % (n=11,094) were simple, 20.1 % (n=3,086) were moderate and 7.6 % (n=1,169) were complex ACHD. Patients with more than moderate ACHD faced a substantially higher risk for adverse outcome regarding all predefined endpoints compared to non-ACHD. Specifically, risk for MACE was increased with an Odds ratio (OR) of 1.29 (95 % CI 1.11-1.51) for moderate ACHD and OR 1.58 (95 % CI 1.23-2.02) for complex ACHD. In-hospital mortality was OR 1.39 (95 % CI 1.13-1.71) for moderate and OR 2.22 (95 % CI 1.62-3.03) for complex ACHD compared to non-ACHD.

Conclusions: Patients with more than moderate complexity ACHD are at specific risk for adverse outcomes when undergoing non-cardiac surgery. Further analyses are needed to give precise recommendations on the choice of appropriate surgical site as well as how to improve care and outcome of ACHD undergoing NCS.

成人先天性心脏病的非心脏手术-疾病复杂性和手术对不良事件的估计风险的影响
背景:提供成人先天性心脏病(ACHD)接受非心脏手术(NCS)的信息,非ACHD的特定风险比较,不良结局和死亡率的独立危险因素。方法:基于2009年至2021年德国所有住院患者的非选择性数据,选择所有接受NCS治疗的ACHD病例。NCS分为低、中、高风险手术。作为主要终点,主要不良心血管事件(MACE)、主要感染(MIE)、主要出血(MBE)、主要血栓栓塞(MTE)和院内死亡被定义。将ACHD的结果与倾向评分匹配的非ACHD队列进行比较。结果:共选取住院ACHD患者15349例进行分析。其中72.3% (n= 11094)为单纯性ACHD, 20.1% (n= 3086)为中度ACHD, 7.6% (n= 1169)为复杂ACHD。与非ACHD相比,中度以上ACHD患者在所有预定终点均面临明显更高的不良结局风险。具体来说,中度ACHD的MACE风险增加,比值比(OR)为1.29 (95% CI 1.11-1.51),复杂ACHD的OR为1.58 (95% CI 1.23-2.02)。与非ACHD相比,中度ACHD的住院死亡率为OR 1.39 (95% CI 1.13-1.71),复杂ACHD的住院死亡率为OR 2.22 (95% CI 1.62-3.03)。结论:中度以上复杂性ACHD患者在接受非心脏手术时存在不良后果的特殊风险。需要进一步的分析,以提供准确的建议,选择合适的手术部位,以及如何改善护理和预后的ACHD行NCS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Internal Medicine
European Journal of Internal Medicine 医学-医学:内科
CiteScore
9.60
自引率
6.20%
发文量
364
审稿时长
20 days
期刊介绍: The European Journal of Internal Medicine serves as the official journal of the European Federation of Internal Medicine and is the primary scientific reference for European academic and non-academic internists. It is dedicated to advancing science and practice in internal medicine across Europe. The journal publishes original articles, editorials, reviews, internal medicine flashcards, and other relevant information in the field. Both translational medicine and clinical studies are emphasized. EJIM aspires to be a leading platform for excellent clinical studies, with a focus on enhancing the quality of healthcare in European hospitals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信